Dow Jones Today, Stocks Soft Before Powell, Day 2; J&J jumps on FDA vaccine remarks | Investor’s Business Daily
The FDA says the Johnson & Johnson vaccine against covid-19 complies with the requirements for emergency use authorization
The FDA responds to the vaccine of a dose against Johnson & Johnson’s COVID-19 and provided a clearance of its use in the United States